Market Place
Sourcing Support
New number of shares and votes in IBT
31 Jul 2023 //
GLOBENEWSWIRE
Additional Infant Bacterial product receives FDA orphan drug designation
03 Jul 2023 //
GLOBENEWSWIRE
New patent for Infant Bacterial Therapeutics has been approved in Europe
15 Jun 2023 //
GLOBENEWSWIRE
IBT publishes prospectus
13 Jun 2023 //
GLOBENEWSWIRE
Extraordinary General Meeting of Infant Bacterial Therapeutics
09 Jun 2023 //
GLOBENEWSWIRE
IBT resolves on a rights issue
16 May 2023 //
GLOBENEWSWIRE
Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
16 May 2023 //
GLOBENEWSWIRE
Notice of Annual General Meeting of Infant Bacterial Therapeutics
03 Apr 2023 //
GLOBENEWSWIRE
IBT opening of a final infant cohort will accelerate patient recruitment
22 Mar 2023 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics publishes Annual Report for 2022
22 Mar 2023 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics AB Interim report January 1- December 31, 2022
10 Feb 2023 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics publishes Annual Report for 2021 in XHTML format
27 Jan 2023 //
GLOBENEWSWIRE
IBT publishes clinical findings in the British Journal of Gastroenterology
24 Jan 2023 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics AB (publ) (IBT), Interim Management Statement
10 Nov 2022 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics AB announces the appointment of the Nomination
04 Nov 2022 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics AB appoints Maria Ekdahl as CFO
30 Jun 2022 //
GLOBENEWSWIRE
Annual General Meeting of Infant Bacterial Therapeutics
04 May 2022 //
GLOBENEWSWIRE
IBT AB (publ) Interim Management Statement, January 1 - March 31, 2022
04 May 2022 //
GLOBENEWSWIRE
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
05 Apr 2022 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics publishes Annual Report for 2021
31 Mar 2022 //
GLOBENEWSWIRE
IBT (publ) Interim Management Statement, January 1 – December 31, 2021
04 Feb 2022 //
GLOBENEWSWIRE
The Connection Study continues after pre-scheduled DMC review
19 Jan 2022 //
GLOBENEWSWIRE
IBT receives new patent protection in Australia
10 Jan 2022 //
GLOBENEWSWIRE
IBT announces new patent protection approvals in Brazil and in Hong Kong
27 Dec 2021 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics announces that a new patent is granted in Mexico
10 Sep 2021 //
GLOBENEWSWIRE
Recruitment of the smallest infants in the Connection study paused
25 Aug 2021 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics AB Interim Management Statement, January 1
13 Aug 2021 //
GLOBENEWS WIRE
Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO
13 Jul 2021 //
GLOBENEWSWIRE
Infant Bacterial Therapeutics AB (publ) Interim Management
04 May 2021 //
GLOBENEWSWIRE
